Efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC)
Authors
Doebele, RAhn, M
Siena, S
Drilon, A
Krebs, Matthew G
Lin, C
De, Braud, F
John, T
Tan, D
Seto, T
Dziadziuszko, R
Arkenau, H
Barlesi, F
Rolfo, C
Wolf, J
Chow-Maneval, E
Multani, P
Cui, N
Riehl, T
Cho, BC
Affiliation
University of Colorado, Aurora, CO/USIssue Date
2018
Metadata
Show full item recordCitation
Doebele R, Ahn M, Siena S, Drilon A, Krebs M, Lin C, et al. OA02.01Efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC). J Thorac Oncol. 2018 Oct;13(10):S321-S322.Journal
Journal of Thoracic OncologyDOI
10.1016/j.jtho.2018.08.239Additional Links
https://dx.doi.org/10.1016/j.jtho.2018.08.239Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.jtho.2018.08.239